North America PDX Models Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Published Report
  • Jul 2018
  • North America
  • 102 Pages
  • No of Tables: 22
  • No of Figures: 34

North America PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), By Geography (U.S., Canada, Mexico) – Trends and Forecast to 2025

North America PDX Models Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization. However, due to high cost of PDX models and strict regulations with respect to the utilization of animal models in cancer research are hindering the market growth.

Market Segmentation: North America PDX Models Market

  • The North America PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
  • The North America PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
  • The North America PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
  • The North America PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
  • Based on geography, the market is segmented into 3 geographical countries

    • U.S.
    • Canada
    • Mexico

Key Drivers: North America PDX Models Market

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

Key Points: North America PDX Models Market

Charles River is going to dominate the North America PDX models market following with Crown Bioscience Inc., Champion Oncology, Inc., The Jackson Laboratory, Oncodesign, Wuxi Apptec, Horizon Discovery Group plc, Pharma test Services Ltd, Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited), MI Bioresearch Inc., EUROPDX, Creative Animodel, Urolead, Xentech, Hera BioLabs and EPO BERLIN-BUCH GMBH among others.

  • The mice models segment is dominating the North America PDX models market.
  • Respiratory tumor models segment is expected to grow with the highest CAGR of 15.1% in the forecast period 2018 to 2025.

SKU-

LIST OF TABLES FIGURES NORTH AMERICA PDX MODELS MARKET

TABLE 1 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2016– 2025, (USD MILLION)

TABLE 2 NORTH AMERICA MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 3 NORTH AMERICA RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 4 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016– 2025 (USD MILLION)

TABLE 5 NORTH AMERICA GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 6 NORTH AMERICA GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 7 NORTH AMERICA RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 8 NORTH AMERICA UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 9 NORTH AMERICA HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 10 NORTH AMERICA OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 11 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2016– 2025 (USD MILLION)

TABLE 12 NORTH AMERICA PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 13 NORTH AMERICA BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 14 NORTH AMERICA PDX MODELS MARKET, BY END USER, 2016– 2025, (USD MILLION)

TABLE 15 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 16 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 17 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 18 NORTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016 – 2025, (USD MILLION)

TABLE 19 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 20 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 21 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 22 NORTH AMERICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 23 U.S. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 24 U.S. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 25 U.S. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 26 U.S. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 27 CANADA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 28 CANADA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 29 CANADA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 30 CANADA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 31 MEXICO PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 32 MEXICO PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 33 MEXICO PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 34 MEXICO PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE